Effects of P2Y12 receptor inhibition in patients with ST-segment elevation myocardial infarction

American Journal of Cardiology

Volumn 113, Issue 12, 2014, Pages 2064-2069

  Alexopoulos, Dimitrios ^a   Xanthopoulou, Ioanna ^a   Goudevenos, John ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CANGRELOR; CLOPIDOGREL; CYTOCHROME P450 2C19; HIRULOG; PLACEBO; PRASUGREL; PURINERGIC P2Y12 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; TICAGRELOR; TIROFIBAN; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACUTE CORONARY SYNDROME; ALLELE; BLOOD CLOT LYSIS; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; DRUG EFFICACY; DRUG POTENCY; FIBRINOLYTIC THERAPY; GENETIC PREDISPOSITION; GENETIC RESISTANCE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE PERFUSION; HUMAN; INTESTINE ABSORPTION; KIDNEY FUNCTION; META ANALYSIS (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATISTICAL SIGNIFICANCE; STENT THROMBOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADMINISTRATION, ORAL; AGED; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84901618316     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.03.053     Document Type: Review

References (32)

1. S.R. Mehta, J.F. Tanguay, J.W. Eikelboom, S.S. Jolly, C.D. Joyner, C.B. Granger, D.P. Faxon, H.J. Rupprecht, A. Budaj, A. Avezum, P. Widimsky, P.G. Steg, J.P. Bassand, G. Montalescot, C. Macaya, G. Di Pasquale, K. Niemela, A.E. Ajani, H.D. White, S. Chrolavicius, P. Gao, K.A. Fox, S. Yusuf CURRENT-OASIS 7 trial investigators Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
2. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
3. G. Montalescot, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, C.H. McCabe, E.M. Antman TRITON-TIMI 38 investigators Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITONTIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
4. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, P.L.A.T.O. Investigators, A. Freij, and M. Thorsén Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
5. P.G. Steg, S. James, R.A. Harrington, D. Ardissino, R.C. Becker, C.P. Cannon, H. Emanuelsson, A. Finkelstein, S. Husted, H. Katus, J. Kilhamn, S. Olofsson, R.F. Storey, W.D. Weaver, L. Wallentin PLATO Study Group Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis Circulation 122 2010 2131 2141
6. D.J. Angiolillo, D.J. Schneider, D.L. Bhatt, W.J. French, M.J. Price, J.F. Saucedo, T. Shaburishvili, K. Huber, J. Prats, T. Liu, R.A. Harrington, and R.C. Becker Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials J Thromb Thrombolysis 34 2012 44 55
7. R.A. Harrington, G.W. Stone, S. McNulty, H.D. White, A.M. Lincoff, C.M. Gibson, C.V. Pollack Jr., G. Montalescot, K.W. Mahaffey, N.S. Kleiman, S.G. Goodman, M. Amine, D.J. Angiolillo, R.C. Becker, D.P. Chew, W.J. French, F. Leisch, K.H. Parikh, S. Skerjanec, and D.L. Bhatt Platelet inhibition with cangrelor in patients undergoing PCI N Engl J Med 361 2009 2318 2329
8. D.L. Bhatt, G.W. Stone, K.W. Mahaffey, C.M. Gibson, P.G. Steg, C.W. Hamm, M.J. Price, S. Leonardi, D. Gallup, E. Bramucci, P.W. Radke, P. Widimský, F. Tousek, J. Tauth, D. Spriggs, B.T. McLaurin, D.J. Angiolillo, P. Généreux, T. Liu, J. Prats, M. Todd, S. Skerjanec, H.D. White, R.A. Harrington CHAMPION PHOENIX Investigators Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med 368 2013 1303 1313
9. P.G. Steg, D.L. Bhatt, C.W. Hamm, G.W. Stone, C.M. Gibson, K.W. Mahaffey, S. Leonardi, T. Liu, S. Skerjanec, J.R. Day, R.S. Iwaoka, T.D. Stuckey, H.S. Gogia, L. Gruberg, W.J. French, H.D. White, R.A. Harrington for the CHAMPION Investigators Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data Lancet 382 2013 1981 1992
10. A. Bellemain-Appaix, D. Brieger, F. Beygui, J. Silvain, A. Pena, G. Cayla, O. Barthélémy, J.P. Collet, and G. Montalescot New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis J Am Coll Cardiol 56 2010 1542 1551
11. A.A. Heestermans, J.W. van Werkum, D. Taubert, T.H. Seesing, N. von Beckerath, C.M. Hackeng, E. Schömig, F.W. Verheugt, and J.M. ten Berg Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction Thromb Res 122 2008 776 781
12. D. Alexopoulos, K.C. Theodoropoulos, E.F. Stavrou, I. Xanthopoulou, G. Kassimis, G. Tsigkas, A. Damelou, P. Davlouros, G. Hahalis, and A. Athanassiadou Prasugrel versus high dose clopidogrel to overcome early high on clopidogrel platelet reactivity in patients with ST elevation myocardial infarction Cardiovasc Drugs Ther 26 2012 393 400
13. S. Biscaglia, M. Tebaldi, P. Vranckx, G. Campo, and M. Valgimigli Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention J Thromb Haemost 11 2013 192 194
14. P. Osmancik, R. Jirmar, K. Hulikova, Z. Peroutka, A. Pompachova, Z. Motovska, and P. Widimsky A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction Catheter Cardiovasc Interv 75 2010 158 166
15. M. Valgimigli, M. Tebaldi, G. Campo, S. Gambetti, L. Bristot, M. Monti, G. Parrinello, R. Ferrari FABOLUS PRO Investigators Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial JACC Cardiovasc Interv 5 2012 268 277
16. D. Alexopoulos, I. Xanthopoulou, V. Gkizas, G. Kassimis, K.C. Theodoropoulos, G. Makris, N. Koutsogiannis, A. Damelou, G. Tsigkas, P. Davlouros, and G. Hahalis Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction Circ Cardiovasc Interv 5 2012 797 804
17. G. Parodi, R. Valenti, B. Bellandi, A. Migliorini, R. Marcucci, V. Comito, N. Carrabba, A. Santini, G.F. Gensini, R. Abbate, and D. Antoniucci Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study J Am Coll Cardiol 61 2013 1601 1606
18. D. Alexopoulos, V. Gkizas, S. Patsilinakos, I. Xanthopoulou, C. Angelidis, P. Anthopoulos, G. Makris, A. Perperis, S. Karanikas, N. Koutsogiannis, P. Davlouros, S. Deftereos, J. Chiladakis, and G. Hahalis Double vs standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI J Am Coll Cardiol 62 2013 940
19. D. Alexopoulos, I. Xanthopoulou, G. Tsigkas, A. Damelou, K.C. Theodoropoulos, G. Kassimis, K. Chouchoulis, P. Davlouros, J. Chiladakis, and G. Hahalis Predictors of high on-treatment platelet reactivity early after clopidogrel loading in ST-elevation myocardial infarction Circ J 76 2012 2183 2187
20. A. Schäfer, U. Flierl, J. Kössler, N. Seydelmann, A. Kobsar, S. Störk, and J. Bauersachs Early determination of clopidogrel responsiveness by platelet reactivity index identifies patients at risk for cardiovascular events after myocardial infarction Thromb Haemost 106 2011 141 148
21. L. Bonello, M. Pansieri, J. Mancini, R. Bonello, L. Maillard, P. Barnay, P. Rossi, O. Ait-Mokhtar, B. Jouve, F. Collet, J.P. Peyre, O. Wittenberg, A. de Labriolle, E. Camilleri, E. Cheneau, E. Cabassome, F. Dignat-George, L. Camoin-Jau, and F. Paganelli High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes J Am Coll Cardiol 58 2011 467 473
22. M. Laine, R. Toesca, J. Berbis, C. Frere, P. Barnay, M. Pansieri, J.P. Peyre, P. Michelet, J. Bessereau, E. Camilleri, O. Helaf, M. Camaleonte, F. Paganelli, F. Dignat-George, and L. Bonello Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention Thromb Res 132 2013 e15 e18
23. P.G. Steg, R.A. Harrington, H. Emanuelsson, H.A. Katus, K.W. Mahaffey, B. Meier, R.F. Storey, D.M. Wojdyla, B.S. Lewis, G. Maurer, L. Wallentin, S.K. James PLATO Study Group Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective randomized PLATO trial Circulation 128 2013 1055 1065
24. E.M. Antman, S.D. Wiviott, S.A. Murphy, J. Voitk, Y. Hasin, P. Widimsky, H. Chandna, W. Macias, C.H. McCabe, and E. Braunwald Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel- Thrombolysis In Myocardial Infarction) analysis J Am Coll Cardiol 51 2008 2028 2033
25. V. Kunadian, S.K. James, D.M. Wojdyla, C. Zorkun, J. Wu, R.F. Storey, P.G. Steg, H. Katus, H. Emanuelsson, J. Horrow, J. Maya, L. Wallentin, R.A. Harrington, and C.M. Gibson Angiographic outcomes in the PLATO trial (Platelet Inhibition and Patient Outcomes) JACC Cardiovasc Interv 6 2013 671 683
26. P.G. Steg, A. van 't Hof, C.W. Hamm, P. Clemmensen, F. Lapostolle, P. Coste, J.T. Berg, P. Van Grunsven, G.J. Eggink, L. Nibbe, U. Zeymer, M.C. Orto, H. Nef, J. Steinmetz, L. Soulat, K. Huber, E.N. Deliargyris, D. Bernstein, D. Schuette, J. Prats, T. Clayton, S. Pocock, M. Hamon, P. Goldstein the EUROMAX Investigators Bivalirudin started during emergency transport for primary PCI N Engl J Med 369 2013 2207 2217
27. T. Simon, C. Verstuyft, M. Mary-Krause, L. Quteineh, E. Drouet, N. Méneveau, P.G. Steg, J. Ferrières, N. Danchin, L. Becquemont French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
28. M.V. Holmes, P. Perel, T. Shah, A.D. Hingorani, and J.P. Casas CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis JAMA 306 2011 2704 2714
29. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, D.X. Zhao, J.L. Anderson, A.K. Jacobs, J.L. Halperin, N.M. Albert, R.G. Brindis, M.A. Creager, D. DeMets, R.A. Guyton, J.S. Hochman, R.J. Kovacs, F.G. Kushner, E.M. Ohman, W.G. Stevenson, C.W. Yancy American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions Circulation 127 2013 e362 e425
30. A. Diego, A.P. de Prado, C. Cuellas, A. de Miguel, B. Samaniego, D. Alonso-Rodríguez, R. Bangueses, B. Vega, J. Martín, and F. Fernandez-Vazquez P2Y12 platelet reactivity after thrombolytic therapy for ST-segment elevation myocardial infarction Thromb Res 130 2012 e31 e36
31. J. Goudevenos, I. Ntalas, I. Xanthopoulou, K. Kalantzi, A. Pipilis, and D. Alexopoulos Use of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysis J Thromb Thrombolysis 2013 Jul 17 [Epub ahead of print http://dx.doi.org/10.1007/s11239-013-0972-2 ]
32. G. Montalescot, J.F. Lassen, C.W. Hamm, F. Lapostolle, J. Silvain, J.M. ten Berg, W.J. Cantor, S.G. Goodman, M. Licour, A. Tsatsaris, and A.W. van't Hof Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study Am Heart J 165 2013 515 522